Private company

Talis Biomedical Corp

American laboratory analytical instruments company, incorporated in Delaware. Summary from the record

Last updated Oct 19, 2026.

Overview

  • IndustryLaboratory Analytical Instruments1
  • HeadquartersChicago, Illinois1
  • Incorporated inDE2
  • Business address1375 West Fulton Market, Suite 700, Chicago, Il 606072
  • Filer category, Emerging growth company2

See how the biggest companies compare on our leaderboards

All references to “Talis Biomedical,” “Talis,” “the Company,” “we,” “our,” and “us” in this Annual Report refer to Talis Biomedical Corporation.3 From its latest annual report

Financials

From the company’s reports to the SEC. Every number links to the filing it came from.

Key numbers, fiscal 2023

-3131.0%Operating margin4
-2905.7%Net margin4
-55.7%Revenue growth, 20234
-89.7%Return on equity4
-$53.7MFree cash flow4

Where the money goes

Where each dollar of revenue went, fiscal 2023

  • Cost of revenue0¢$41.0K
  • Research and development59¢$40.7M
  • Selling, general and admin41¢$28.2M

Out of $2.1M in revenue.4 The company lost money this year.

Financial statements

Revenue54$2.1M in 2023−74% since 2021
0$2.5M$5.0M$7.5M$10.0M2021: $8.2M$8.2M20212022: $4.8M$4.8M2022−41%2023: $2.1M$2.1M2023−56%
Operating income654-$66.8M in 2023−27% since 2020
-$200.0M-$150.0M-$100.0M-$50.0M02020: -$91.2M-$91.2M20202021: -$191.8M-$191.8M2021+110%2022: -$115.1M-$115.1M2022−40%2023: -$66.8M-$66.8M2023−42%
Net income654-$62.0M in 2023−32% since 2020
-$200.0M-$150.0M-$100.0M-$50.0M02020: -$91.1M-$91.1M20202021: -$192.0M-$192.0M2021+111%2022: -$113.0M-$113.0M2022−41%2023: -$62.0M-$62.0M2023−45%
Fiscal year20192020202120222023
Revenue$8.2M5$4.8M4$2.1M4
Cost of revenue$05$8.4M4$41.0K4
Research and development$89.0M6$157.6M5$70.8M4$40.7M4
Selling, general and admin$13.1M6$42.4M5$40.7M4$28.2M4
Operating expenses$200.0M6$120.0M4$68.9M4
Operating income-$91.2M6-$191.8M5-$115.1M4-$66.8M4
Income tax$06$05$04$04
Net income-$91.1M6-$192.0M5-$113.0M4-$62.0M4
Earnings per share-$8.485-$62.774-$34.124
Earnings per share (diluted)-$8.485-$62.774-$34.124
Shares (weighted, basic)22.7M shares51.8M shares41.8M shares4
Shares (weighted, diluted)22.7M shares51.8M shares41.8M shares4

Compare Talis Biomedical Corp with another company

Leadership

Who has led Talis Biomedical Corp, and when. Pick a name to see everywhere that person has worked.

Chief executive

  1. Brian Coe2021
  2. Kimberly J. Popovits2021
  3. Brian J. Blaser2021

President

  1. Brian J. Blaser2021
  2. Andrew A. Lukowiak2023

Chief financial officer

  1. Rebecca Markovich2023

Chief operating officer

  1. Douglas Liu2021
2025
Board members and other officers (17)

Former names

  • SlipChip CorpAug 20, 2013 to Oct 17, 20172

Timeline

  1. Dec 2, 2021New chief executive Brian J. Blaser becomes CEO11
  2. Aug 31, 2021New chief executive Kimberly J. Popovits becomes CEO10
  3. Feb 11, 2021New chief executive Brian Coe becomes CEO9

Filings

123 filings to the SEC since October 2021: 3 annual reports, 9 quarterly reports, 37 major events, 38 insider forms, 12 large holders, 24 other. The latest 20:

  1. Oct 10, 2024SC 13D/A EDGAR
  2. Sep 30, 202415-12G EDGAR
  3. Sep 17, 20248-K EDGAR
  4. Sep 9, 20244 EDGAR
  5. Sep 9, 2024S-8 POS EDGAR
  6. Sep 9, 2024S-8 POS EDGAR
  7. Sep 9, 2024S-8 POS EDGAR
  8. Sep 9, 2024S-8 POS EDGAR
  9. Sep 6, 20248-K EDGAR
  10. Sep 5, 20244 EDGAR
  11. Sep 5, 20248-K/A EDGAR
  12. Sep 4, 20244 EDGAR
  13. Sep 3, 20248-K EDGAR
  14. Aug 28, 20244 EDGAR
  15. Aug 23, 20248-K EDGAR
  16. Aug 19, 202410-Q EDGAR
  17. Aug 14, 2024SC 13G/A EDGAR
  18. Aug 14, 20243 EDGAR
  19. Aug 14, 2024SC 13G EDGAR
  20. Aug 14, 2024NT 10-Q EDGAR

The 123 filings since October 2021 can be filtered by form type and year here when JavaScript is on.

Every filing from the last five years, summarized. The full record is on SEC EDGAR.

Insider trades

7 open-market trades by officers, directors and large owners since October 2021: 7 buys and 0 sales. Grants, option exercises and gifts are left out.

DateWhoTradeSharesPriceValueFiling
Sep 6, 2024Leonard Braden Michael10% ownerBuy25,000$1.48$37.0KForm 4
Sep 5, 2024Leonard Braden Michael10% ownerBuy5,100$1.40$7.1KForm 4
Sep 3, 2024Leonard Braden Michael10% ownerBuy500$4.00$2.0KForm 4
Aug 30, 2024Leonard Braden Michael10% ownerBuy151$4.25$642Form 4
Aug 28, 2024Leonard Braden Michael10% ownerBuy1,215$3.96$4.8KForm 4
Aug 26, 2024Leonard Braden Michael10% ownerBuy13,167$3.90$51.4KForm 4
Nov 18, 2021BAKER BROS. ADVISORS LPDirectorBuy50,000$4.37$218.5KForm 4

From Forms 4 filed with the SEC.

Major holders

Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.

Sources

The numbers on this page point here. Each one links to the record it came from.

  1. 1
  2. 2
  3. 3
  4. 4
  5. 5
  6. 6
  7. 7
  8. 8
  9. 9
  10. 10
  11. 11
  12. 12
  13. 13
  14. 14
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19
  20. 20
  21. 21
  22. 22
  23. 23
  24. 24
  25. 25
  26. 26
  27. 27
  28. 28
  29. 29
  30. 30
  31. 31
  32. 32